ArticleEye (London, England)2021

Response to 'Comment on: "Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases"'.

Ivan Seah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.